Synthon Sets Its Sights on Drugs For Cancer and Autoimmune Diseases.(Brief Article) From: Chemical Market Reporter | Date: April 23, 2001| Author: JARVIS, LISA | COPYRIGHT 2001 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

SYNTHON CHIRAGENICS Corp. has broadened the reach of its carbohydrate-based chiral technology platform into a hot area of drug discovery, carbohydrate-based therapeutics. Using its technology to prepare molecules that regulate complex carbohydrate and nucleic acid synthesis, Synthon is developing a new class of pharmaceuticals for cancer treatment and a range of autoimmune diseases.

The primary goal of the platform is the inhibition of the purine nucleoside phosphorylase...

Related newspaper, magazine, and journal articles from HighBeam Research

	Automated nucleic acid prep. (New Products).(Tecan U.S.)(Brief Article) Bioscience Technology ; Automation Suites perform a number of techniques for the isolation, purification, amplification and analysis of nucleic acids (DNA or RNA). The first two suites en-compass a full range of technologies for nucleic acid sample preparation and nucleic acid reactions. The Nucleic Acid Sample
	Design of Minimally Strained Nucleic Acid Nanotubes Biophysical Journal ; ABSTRACT A practical theoretical framework is presented for designing and classifying minimally strained nucleic acid nanotubes. The structures are based on the double crossover motif where each double-helical domain is connected to each of its neighbors via two or more Holliday-junctionlike
	Single-Tube Method for Nucleic Acid Extraction, Amplification, Purification, and Sequencing Clinical Chemistry ; Background: The hepatitis C virus (HCV) genotype determines patient prognosis and duration of treatment, but sequencing of the gene is lengthy and labor-intensive. We used a commercially available nucleic acid extraction system to develop a single-tube extraction-to-sequencing (STETS) method for
	Nucleic acid drug delivery, part 1: Delivery issues related to dividing cells Biopharm ; The promise of nucleic acid pharmaceuticals cannot be fulfilled until the delivery problem is solved. This review covers issues including insufficient uptake and expression in dividing cells. Part 2 will address similar issues in nondividing cells. Nucleic acid pharmaceuticals are of increasing
	Nucleic acid diagnostics for fresh water pathogens. (Feature/Chronique).(procedure developed by University of Toronto scientists) Canadian Chemical News ; A new DNA-based procedure is poised to dramatically reduce the time it takes to assess the bacterial contamination of water, the cause of the Walkerton tragedy. A University of Toronto team is working on a tool that can be used for everthing from the rapid monitoring of beach and drinking water

See all results.